Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

After price cut, NICE backs Saxenda from Novo Nordisk for use by NHS in England for obesity, ending a 10-year drought in new drug therapies ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

KATIE Price has revealed son Harvey will “hopefully” start weight loss injections this week in an attempt to save his life. The former glamour model is worried about the disabled 22-yea… ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

For CVS HealthCVS, the key to building customer trust is to enhance access to life-changing medications and also make them ...

THEY are arguably the biggest medical breakthrough of recent times. And from this week, so-called ‘fat jabs’ will be made ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.